NovoLog Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Alerts
• Clinical Trials
• Forums

Novolog vs. Fiasp Insulin in Non-critically Ill Hospitalized Patients With Type 2 Diabetes Mellitus
Condition:   Type 2 Diabetes Treated With Insulin Interventions:   Drug: Insulin glargine;   Drug: NovoLog;   Drug: Insulin Fiasp;   Other: Standard carbohydrate diet Sponsors:   Boston Medical Center;   Novo Nordisk A/S Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 7, 2020 Category: Research Source Type: clinical trials

Safety and Efficacy of Combining Intranasal Insulin & Acute Exercise
Conditions:   Insulin;   Exercise Interventions:   Drug: Placebo into the intranasal mucosa;   Drug: 20 IU NovoLog Insulin aspart into the intranasal mucosa;   Drug: 40 IU NovoLog Insulin aspart into the intranasal mucosa;   Drug: 60 IU NovoLog Insulin aspart into the intranasal mucosa;   Drug: 80 IU NovoLog Insulin aspart into the intr anasal mucosa;   Drug: 100 IU NovoLog Insulin aspart into the intranasal mucosa;   Drug: 120 IU NovoLog Insulin aspart into the intranasal mucosa Sponsor:   Michigan State University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 3, 2020 Category: Research Source Type: clinical trials